Manipal Health Enterprises Ltd has fully redeemed its outstanding listed non-convertible debentures worth ₹5,310 crore using proceeds from its initial public offering, in line with its prospectus. The company said the move will reduce interest costs and strengthen its balance sheet. Alongside the announcement, it reported Q1 FY27 revenue of ₹3,091 crore, EBITDA of ₹749 crore and adjusted profit after tax of ₹332 crore, reflecting continued operational growth.
Manipal Health Redeems ₹5,310 Crore NCDs After IPO
Debt Redeemed: ₹5,310 crore listed NCDs
Q1 FY27 Revenue: ₹3,091 crore, up 38.1% year-on-year
Reader Takeaway: Lower leverage supports growth, though execution of expansion plans remains key.
What just happened
Manipal Health Enterprises Ltd has completed the full redemption of its outstanding listed non-convertible debentures amounting to ₹5,310 crore.
The repayment was funded through proceeds from the company's initial public offering, in line with the stated objects of the prospectus dated July 31, 2026.
According to the company, the redemption includes the entire principal amount, accrued interest and all applicable prepayment or early redemption costs.
Why this matters
The transaction represents a significant deleveraging milestone for the company.
Management said the repayment is expected to strengthen the balance sheet, reduce interest expenses and improve financial flexibility for future investments in hospital capacity, technology and talent.
Using IPO proceeds for the intended purpose also reflects adherence to the capital allocation plan disclosed to investors before listing.
The backstory
Alongside the debt update, Manipal Health released its Q1 FY27 financial performance.
Revenue rose 38.1% year-on-year to ₹3,091 crore.
EBITDA increased 26.4% to ₹749 crore, while adjusted profit after tax grew 30.9% to ₹332 crore. Reported profit after tax stood at ₹243 crore.
What changes now
Following the redemption, the company will no longer carry the redeemed listed NCDs on its balance sheet.
Lower borrowing costs could support future earnings, while increased financial headroom may provide flexibility to pursue expansion initiatives across its healthcare network.
Risks to watch
- Execution of future capacity expansion plans.
- Sustaining revenue and earnings growth.
- Deployment of capital into new investments.
- Operating performance after the deleveraging exercise.
What to track next
Investors should monitor the impact of lower finance costs on future quarterly earnings, progress on expansion projects and the company's ability to maintain strong operating growth while investing in additional healthcare infrastructure.